ASND ASCENDIS PHARMA A/S
FollowORD SHS *A* (common), issuer CIK 1612042
Filings received so far for Q3 2026: 9 13F filers report a position in ASND shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| SAPIENT CAPITAL LLC | 95,721 | $21.8M | 0.29% | +3,559 | 13F-HRTimeline |
| TOTH FINANCIAL ADVISORY CORP | 4,830 | $1.1M | 0.11% | -1,050 | 13F-HRTimeline |
| GAMMA Investing LLC | 1,581 | $360K | 0.01% | +544 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 609 | $139K | <0.01% | new | 13F-HRTimeline |
| Bank of New Hampshire | 72 | $16.4K | <0.01% | 0 | 13F-HRTimeline |
| Roxbury Financial LLC | 42 | $9.57K | 0.01% | new | 13F-HRTimeline |
| MassMutual Private Wealth & Trust, FSB | 16 | $3.65K | <0.01% | +12 | 13F-HRTimeline |
| Versant Capital Management, Inc | 6 | $1.37K | <0.01% | new | 13F-HRTimeline |
| ARMSTRONG ADVISORY GROUP, INC | 3 | $684 | <0.01% | new | 13F-HRTimeline |